Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.
Davie
Michael
M
D000928:Antidepressive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000077465:Cabergoline; D015283:Citalopram / Q000627:therapeutic use; D003702:Delusions / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D004873:Ergolines / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005715:Gambling / Q000523:psychology*; D006801:Humans; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000523:psychology*; D015175:Prolactinoma / Q000150:complications* / Q000188:drug therapy / Q000523:psychology*
D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D004873:Ergolines; D015283:Citalopram; D000077465:Cabergoline